Persistent Asset Partners’s XBiotech XBIT Stock Holding History

Persistent Asset Partners’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,565	Closed	-$32.4K	–	487
2025 Q4	$32.4K	Buy	+13,565	New	+$33.4K	0.01%	305

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Persistent Asset Partners's XBIT Position: Q1 2026 in Review

Persistent Asset Partners sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 13,565 shares — an estimated $32.4K sold.

Persistent Asset Partners first reported a position in XBIT in Q4 2025 and held it in 1 quarter. The position peaked at $32.4K in Q4 2025. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

Persistent Asset Partners reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
Persistent Asset Partners sold 13,565 XBiotech shares in Q1 2026, an estimated $32.4K.
Persistent Asset Partners first reported a position in XBiotech in Q4 2025 and held it in 1 quarter.
Persistent Asset Partners's XBiotech position peaked at $32.4K in Q4 2025.
37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.